Clinical Trial Update: Apatinib Plus Anti-PD1 Therapy for Advanced Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating apatinib plus anti-PD1 therapy in advanced osteosarcoma has completed, reporting measures such as progression-free survival, ove…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Anti-PD1 therapy
• Apatinib (apatinib)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Progression-free Survival, Overall Survival | Phase 2 | Status: COMPLETED